LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Methotrexate-induced pseudotumor cerebri in a patient with juvenile idiopathic arthritis

Photo by curvd from unsplash

Pseudotumor cerebri (PTC) is a rare neurological disorder characterized by increased intracranial pressure in the absence of any intracranial space-occupying lesion. PTC may be primary or occur secondary to certain… Click to show full abstract

Pseudotumor cerebri (PTC) is a rare neurological disorder characterized by increased intracranial pressure in the absence of any intracranial space-occupying lesion. PTC may be primary or occur secondary to certain conditions. In secondary cases, some conditions including certain medications, endocrine abnormalities, autoimmune disorders, anemias, infectious or postinfectious processes, and cranial venous outflow abnormalities have been identified as causative agents [1]. Methotrexate (MTX) is one of the most effective and widely used medications for treating juvenile idiopathic arthritis (JIA) and other inflammatory types of arthritis [2]. However, MTX may result in adverse effects including hepatic, pulmonary, and renal toxicity as well as lymphoproliferative disorders and predisposition to infection [2, 3]. There has been only one report of PTC in association with MTX in an adult patient in the literature [4]. We report a case of PTC in a patient with JIA due to MTX therapy. To our knowledge, this is the first case of MTX-induced PTC in children.

Keywords: pseudotumor cerebri; juvenile idiopathic; idiopathic arthritis

Journal Title: Acta Neurologica Belgica
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.